{"resourceType": "EvidenceVariable", "meta": {"versionId": "3", "lastUpdated": "2023-12-01T22:26:01.820Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"]}, "title": "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis", "useContext": [{"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"text": "group-assignment"}}], "status": "active", "url": "https://fevir.net/resources/EvidenceVariable/179784", "id": "179784", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "179784", "assigner": {"display": "Computable Publishing LLC"}}], "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Brian S. Alper"}], "name": "Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis", "description": "Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19", "definition": {"concept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "defined-in-handling-and-category", "display": "Defined in handling and category elements"}]}}, "handling": "dichotomous", "category": [{"name": "Therapeutic-dose anticoagulation with heparin", "valueReference": {"reference": "Group/179786", "type": "Group", "display": "ExposureDefinition: Therapeutic-dose anticoagulation with heparin"}}, {"name": "Usual-care pharmacologic thromboprophylaxis", "valueReference": {"reference": "Group/179785", "type": "Group", "display": "ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis"}}], "relatesTo": [{"type": "cite-as", "targetMarkdown": "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784."}]}